X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tcf3-pbx1 (15) 15
humans (13) 13
index medicus (11) 11
male (11) 11
adolescent (10) 10
hematology (10) 10
oncology (10) 10
t (10) 10
oncogene proteins, fusion - genetics (9) 9
female (8) 8
child (7) 7
child, preschool (7) 7
infant (7) 7
pediatrics (7) 7
precursor cell lymphoblastic leukemia-lymphoma - genetics (7) 7
acute lymphoblastic leukemia (6) 6
leukemia (6) 6
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (6) 6
translocation, genetic (6) 6
acute lymphocytic leukemia (5) 5
cancer (5) 5
children (5) 5
research (5) 5
risk (5) 5
analysis (4) 4
chromosomes, human, pair 1 (4) 4
disease-free survival (4) 4
genes (4) 4
genetic aspects (4) 4
hemic and lymphatic diseases (4) 4
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (4) 4
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (4) 4
prognosis (4) 4
acute lymphatic leukemia (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
basic helix-loop-helix transcription factors - genetics (3) 3
bcr-abl1 (3) 3
chemotherapy (3) 3
chromosomes (3) 3
chromosomes, human, pair 1 - genetics (3) 3
chromosomes, human, pair 19 (3) 3
chromosomes, human, pair 19 - genetics (3) 3
dna mutational analysis (3) 3
dna-binding proteins - genetics (3) 3
gene expression (3) 3
genomics (3) 3
hyperdiploidy (3) 3
ikzf1 (3) 3
medical prognosis (3) 3
patients (3) 3
pax5 transcription factor - genetics (3) 3
pre-b-cell leukemia transcription factor 1 (3) 3
precursor cell lymphoblastic leukemia-lymphoma - mortality (3) 3
proto-oncogene proteins - genetics (3) 3
therapy (3) 3
translocations (3) 3
acute lymphoblastic-leukemia (2) 2
adult (2) 2
all (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
article (2) 2
asparaginase - therapeutic use (2) 2
blood (2) 2
bone marrow (2) 2
case report (2) 2
central nervous system (2) 2
central nervous system leukemia (2) 2
childrens cancer group (2) 2
cns relapse (2) 2
combined modality therapy (2) 2
consolidation therapy (2) 2
context (2) 2
cytogenetics (2) 2
daunorubicin - therapeutic use (2) 2
early pre-b all (2) 2
early t-cell precursor all (2) 2
embryonic structures (2) 2
etv6-runx1 (2) 2
fatal outcome (2) 2
fish (2) 2
fusion transcripts (2) 2
gene (2) 2
gene mutations (2) 2
gene rearrangement (2) 2
genetics & heredity (2) 2
health aspects (2) 2
hematopoietic stem cell transplantation (2) 2
hypodiploidy (2) 2
immunophenotyping (2) 2
incidence (2) 2
internal medicine (2) 2
lymphatic leukemia (2) 2
lymphocytic leukemia (2) 2
maintenance therapy (2) 2
medical research (2) 2
medicine & public health (2) 2
minimal residual disease (2) 2
mll-aff1 (2) 2
notch1 (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatric Blood & Cancer, ISSN 1545-5009, 10/2017, Volume 64, Issue 10, p. n/a
Journal Article
NATURE GENETICS, ISSN 1061-4036, 09/2015, Volume 47, Issue 9, pp. 1020 - 1020
TCF3-HLF-positive acute lymphoblastic leukemia (ALL) is currently incurable. Using an integrated approach, we uncovered distinct mutation, gene expression and... 
PROGENITOR CELLS | CHROMOSOMAL TRANSLOCATIONS | SET ENRICHMENT ANALYSIS | RAS PATHWAY | GENETICS & HEREDITY | GENE-EXPRESSION | B-CELL DIFFERENTIATION | SEQUENCING DATA | CHAIN REARRANGEMENT | TRANSCRIPTION FACTOR | HEMATOPOIETIC STEM | Sequence Deletion | Oncogene Proteins, Fusion - metabolism | Coculture Techniques | Genomics | Humans | Drug Resistance, Neoplasm | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antineoplastic Agents - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | DNA Mutational Analysis | Inhibitory Concentration 50 | Female | Antineoplastic Agents - pharmacology | Immunoglobulin Light Chains, Surrogate - genetics | Gene Expression | Genetic Association Studies | Kaplan-Meier Estimate | PAX5 Transcription Factor - genetics | Mice, SCID | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | Animals | Oncogene Proteins, Fusion - genetics | Mice, Inbred NOD | Mutation | Cohort Studies | Gene mutations | Genetic aspects | Acute lymphocytic leukemia | Research | Identification and classification | Health aspects | Risk factors | Bone marrow | Genes | Leukemia | cytarabine | integrative | leukemic stem cell | drug activity profiling | panobinostat | mTOR inhibitor | genomics | glucocorticoids | bortezomib | ABT-199 | dexamethasone | HSP90 | TCF3-PBX1 | vincristine | BH3-mimetics | leukemia xenograft model | next generation sequencing | TCF3-HLF | venetoclax | anthracycline | acute lymphoblastic leukemia | AUY922 | BCL2 | drug resistance | prednisone
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 2009, Volume 23, Issue 8, pp. 1406 - 1409
To evaluate the impact of contemporary therapy on the clinical outcome of children with pre-B acute lymphoblastic leukemia (ALL) and the t(1;19)/TCF3/PBX1, we... 
t(1;19) | TCF3-PBX1 | PROGNOSIS | pediatric ALL | CHEMOTHERAPY | CHILDREN | CNS relapse | THERAPY | ONCOLOGY | T(1-19)(Q23-P13) | ACUTE LYMPHOBLASTIC-LEUKEMIA | DISEASE | HEMATOLOGY | pre-B ALL | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Clinical Trials as Topic - statistics & numerical data | Humans | Central Nervous System - pathology | Child, Preschool | Infant | Male | Risk | Leukemic Infiltration - epidemiology | Chromosomes, Human, Pair 19 - ultrastructure | Incidence | Chromosomes, Human, Pair 19 - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Female | Chromosomes, Human, Pair 1 - genetics | Child | Injections, Spinal | Risk Assessment | Proportional Hazards Models | Genotype | Treatment Outcome | Combined Modality Therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy | Cranial Irradiation | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Leukemic Infiltration - prevention & control | Oncogene Proteins, Fusion - genetics | Chromosomes, Human, Pair 1 - ultrastructure | Adolescent | Leukemia | Central nervous system diseases | Physiological aspects | Genetic aspects | Research | B cells | Gene expression | Pre-B ALL | Pediatric ALL
Journal Article
Leukemia, ISSN 0887-6924, 2009, Volume 23, Issue 11, pp. 1989 - 1998
Journal Article
Cancer Medicine, ISSN 2045-7634, 06/2014, Volume 3, Issue 3, pp. 623 - 631
Journal Article
Biomarker research, ISSN 2050-7771, 2015, Volume 3, Issue 1, pp. 4 - 4
The t(1;19)(q23;p13), which can result in the TCF3-PBX1 chimeric gene, is one of the most frequent translocations in B-acute lymphoblastic leukemia (B-ALL) and... 
Cytogenetics | Genes
Journal Article
BMC Medical Genomics, ISSN 1755-8794, 12/2018, Volume 11, Issue 1, pp. 122 - 5
Journal Article
Laboratory Medicine Online, ISSN 2093-6338, 2013, Volume 3, Issue 2, p. 110
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2011, Volume 94, Issue 2, pp. 203 - 208
Journal Article
Journal Article
2013, 5th ed. 2013, ISBN 9781461437635
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.